Mankind Pharma Stock

Mankind Pharma P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Mankind Pharma (MANKIND.NS) as of Aug 19, 2026 is 44.30. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 48.74 — a change of -9.12% (lower).

P/FCF

44.30

YoY

-9.12%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Mankind Pharma is 2026 44.30 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Mankind Pharma was 2025 48.74 . It decreases by -9.12% lower compared to the previous year.
Access this data via the Eulerpool API

Mankind Pharma Stock analysis

What does Mankind Pharma do? Mankind Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mankind Pharma stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Mankind Pharma is 44.30 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Mankind Pharma changed from 48.74 to 44.30, representing a -9.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Mankind Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Mankind Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Mankind Pharma

All Key Metrics — Mankind Pharma